Organisation paid for research Program year 2022 Source: CMS Open Payments

American Thrombosis + Hemostasis

Neither a doctor nor a teaching hospital

Research payments

$913,806

4 payments

Through program year 2022, American Thrombosis + Hemostasis is reported as receiving $913,806 in research payments, across 4 payments.

By program year

1 row
Year Kind Amount Payments
2022 Research $913,806 4

Breakdown

Who paid Research payments · program year 2022
  1. Genentech, Inc. $913,806 4 payments
Studies the money was for Research payments · program year 2022
  1. An Observational Cohort Study of People With Hemophilia With and Without Inhibitors Treated With Current Therapy Or A Non-Factor Product A Study of Safety, Effectiveness and Practice Athn 7 $463,992 2 payments
  2. Pre-Clinical4202022 $227,820 1 payment
  3. Pre-Clinical1122022 $221,994 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record